Peroxisome proliferator-activated receptor b/d (PPARb/d) is a potential regulator of neuroinflammation. Toll-like receptors (TLR) are innate immunity-related receptors of inflammatory stimuli. In the present report, we evaluate the molecular mechanisms of regulation of mRNA, protein, and transcriptional activity levels of PPARb/d by agonists of TLR4, TLR1/2, and TLR5, using lipopolysaccharide (LPS), peptidoglycan, and flagellin, respectively. We found that these stimuli increase the PPARb/d levels in astrocytes. Expression and activity of PPARb/d are separately regulated by inhibitors of p38, MEK1/ 2, extracellular signal-regulated kinases 1/2, and c-Jun Nterminal Kinase mitogen-activated protein kinases. The LPSinduced kinetics of PPARb/d expression is similar to that of the proinflammatory gene cyclooxygenase 2. Moreover, for both genes the expression depends on nuclear factor kappa-lightchain-enhancer of activated B cells and p38, and is induced after inhibition of protein synthesis. The up-regulation of the expression after inhibition of protein synthesis signifies the participation of a labile protein in regulation of PPARb/d expression. In contrast to cyclooxygenase 2, the cycloheximide-sensitive PPARb/d expression was not responsive to nuclear factor kappa-light-chain-enhancer of activated B cells inhibition. Measurements of PPARb/d mRNA stability showed that the PPARb/d mRNA levels are regulated post-transcriptionally. We found that in LPS-stimulated astrocytes, the halflife of PPARb/d mRNA was 50 min. Thus, we demonstrate that PPARb/d expression and activity are regulated in TLR agoniststimulated astrocytes by mechanisms that are widely used for regulation of proinflammatory genes.